BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Treatment
10 results:

  • 1. [Mean features of the nephron- sparing surgery in older patients with localized renal cell carcinoma].
    Kotov SV; Nemenov AA; Yusufov AG; Guspanov RI; Pulbere SA; Nemenova DM
    Urologiia; 2022 Dec; (6):84-88. PubMed ID: 36625619
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A meta-analysis of the platelet-lymphocyte ratio: A notable prognostic factor in renal cell carcinoma.
    Zhou X; Luo G
    Int J Biol Markers; 2022 Jun; 37(2):123-133. PubMed ID: 35238678
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study.
    Gu L; Peng C; Zhang F; Fang C; Guo G
    Orphanet J Rare Dis; 2021 Jun; 16(1):277. PubMed ID: 34127034
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pure retroperitoneal laparoscopic radical nephrectomy and thrombectomy with delayed occlusion of the proximal inferior vena cava (DOPI) technique for renal tumor with level II-III venous tumor thrombus.
    Liu Z; Hong P; Zhu G; Zhang L; Zhao X; Tang S; Yang F; Tian X; Wang G; Zhang S; Zhang H; Huang Y; Liu C; Liu C; Ma L
    BMC Cancer; 2021 May; 21(1):627. PubMed ID: 34044812
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Real-World Outcomes Among US Veterans Health Administration Patients Newly Diagnosed with Metastatic Renal Cell Carcinoma and Treated with First-Line Monotherapy.
    Bhanegaonkar A; Pandya S; Zheng Y; Kim R; Krulewicz S; Kasturi V; Phatak H
    Adv Ther; 2021 May; 38(5):2644-2661. PubMed ID: 33866526
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Management Strategies and Patient Selection After a Hospital Funding Reform for Prostate Cancer Surgery in Canada.
    Wettstein MS; Palmer KS; Kulkarni GS; Paterson JM; Ling V; Lapointe-Shaw L; Li AH; Brown A; Taljaard M; Ivers N
    JAMA Netw Open; 2019 Aug; 2(8):e1910505. PubMed ID: 31469400
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Use of "Real-World" data to describe adverse events during the treatment of metastatic renal cell carcinoma in routine clinical practice.
    Hirsch BR; Harrison MR; George DJ; Walker MS; Chen C; Korytowsky B; Stepanski E; Abernethy AP
    Med Oncol; 2014 Sep; 31(9):156. PubMed ID: 25115744
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Outcomes in patients undergoing nephrectomy for renal cancer on chronic anticoagulation therapy.
    Sfakianos JP; Hakimi AA; Kim PH; Zabor EC; Mano R; Bernstein M; Karellas M; Russo P
    Eur J Surg Oncol; 2014 Dec; 40(12):1700-5. PubMed ID: 24813810
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Does renal damage occur after the administration of 32P for palliation of pain from skeletal metastases?
    Nair N; Mahadeo DS; Patel R
    Nucl Med Commun; 1998 Jul; 19(7):689-93. PubMed ID: 9853350
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immune-complex disease in mice and humans given C. parvum.
    Mitcheson HD; Uff J; Pussell BA; Brill M; Castro JE
    Br J Cancer; 1980 Jul; 42(1):34-40. PubMed ID: 6448615
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.